NCT06553846View on ClinicalTrials.gov

A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 19, 2024

Primary Completion Date

February 18, 2025

Study Completion Date

August 18, 2025

Conditions
Solid Tumors
Interventions
DRUG

Lutetium [177Lu]-FAP-75

Lutetium \[177Lu\]-FAP-75 will be administrated per dose level in which the patients are assigned.

Trial Locations (1)

200032

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center;Pancreatic Cancer Institute, Fudan University, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT06553846 - A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter